Statins [orch, phsu]
Aspirin [orch, phsu]
Chemoprevention [topp]
Barrett Esophagus [dsyn]
Result [ftcn]
Cost Effectiveness Analysis [ocac]
Data [idcn]
Suggest [idcn]
Aspirin [orch, phsu]
Statins [orch, phsu]
Combination [qlco]
Two [qnco]
Drugs [phsu]
Lower [spco]
progression [patf]
Barrett Esophagus [dsyn]
Esophageal Adenocarcinoma [neop]
Aspirin [orch, phsu]
Associated [qlco]
Potential [qlco]
Complications [patf]
Gastrointestinal bleeding [patf]
Haemorrhagic stroke [patf]
Statins [orch, phsu]
Associated [qlco]
Myopathy [dsyn]
Simulation [resa]
Disease model [emod]
Study [mnob]
Effectiveness [qlco]
Cost Effectiveness [qnco]
Aspirin [orch, phsu]
Statin [orch, phsu]
Chemoprevention [topp]
Esophageal Adenocarcinoma [neop]
Decision [menp]
Model [inpr]
Construct [clas]
To [qlco]
Compare [acty]
Four [qnco]
strategies [menp]
Barrett Esophagus [dsyn]
Management [ocac]
regimens [inpr]
included [ftcn]
Standard [qlco]
Endoscopic [diap]
surveillance [ftcn]
regimens [inpr]
I- [inch]
Endoscopic [diap]
surveillance [ftcn]
Alone [qnco]
Aspirin [orch, phsu]
therapy [ftcn]
III [inpr]
Statin [orch, phsu]
therapy [ftcn]
Combination Therapy [topp]
Aspirin [orch, phsu]
Statin [orch, phsu]
endpoints [qlco]
Evaluated [ftcn]
Life Expectancy [grpa]
Quality-Adjusted Life Years [tmco]
Costs [qnco]
Incremental [qnco]
Cost Effectiveness [qnco]
Ratio [qnco]
Sensitivity [qnco]
Analysis [lbpr]
Performed [ftcn]
To [qlco]
IMPACT [gngm]
Model [inpr]
Input [cnce]
Uncertainty [idcn]
Result [ftcn]
Annual [tmco]
progression [patf]
Rate [acty]
Barrett Esophagus [dsyn]
Esophageal Adenocarcinoma [neop]
Aspirin [orch, phsu]
therapy [ftcn]
More [ftcn]
effective [qlco]
Cost [qnco]
Endoscopic [diap]
surveillance [ftcn]
Alone [qnco]
Combination Therapy [topp]
Compared [acty]
Aspirin [orch, phsu]
therapy [ftcn]
Incremental [qnco]
Cost Effectiveness [qnco]
Ratio [qnco]
Quality-Adjusted Life Years [tmco]
Willing [fndg]
pay [qnco]
Threshold [qlco]
Quality-Adjusted Life Years [tmco]
Statin [orch, phsu]
therapy [ftcn]
Combination Therapy [topp]
High [qlco]
Annual [tmco]
cancer progression [neop]
Rate [acty]
Assumed [inpr]
Model [inpr]
Combination Therapy [topp]
Cost Effectiveness [qnco]
Compared [acty]
Aspirin [orch, phsu]
therapy [ftcn]
Incremental [qnco]
Cost Effectiveness [qnco]
Ratio [qnco]
Quality-Adjusted Life Years [tmco]
Conclusion [idcn]
Aspirin [orch, phsu]
Chemoprevention [topp]
More [ftcn]
effective [qlco]
Cost [qnco]
Endoscopic [diap]
surveillance [ftcn]
Alone [qnco]
Combination Therapy [topp]
Using [ftcn]
Aspirin [orch, phsu]
Statin [orch, phsu]
expense [qnco]
Cost Effectiveness [qnco]
Patients [podg]
High Risk [qlco]
progression [patf]
Esophageal Adenocarcinoma [neop]
[c] [qnco]
AACR [pros]
